DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Apocynin is an investigational drug.
There have been 4 clinical trials for Apocynin. The most recent clinical trial was a Phase 1 trial, which was initiated on September 9th 2020.
The most common disease conditions in clinical trials are Lung Diseases, Obstructive, Lung Diseases, and Asthma. The leading clinical trial sponsors are Ministry of Science and Higher Education, Poland, Medical University of Lodz, and Medical Universtity of Lodz.
There are six hundred and seven US patents protecting this investigational drug and three international patents.
Recent Clinical Trials for Apocynin
|A Trial of APPA in the Treatment of Knee Osteoarthritis||NBCD A/S||Phase 2|
|A Trial of APPA in the Treatment of Knee Osteoarthritis||Nordic Bioscience A/S||Phase 2|
|A Trial of APPA in the Treatment of Knee Osteoarthritis||AKL Research and Development||Phase 2|
Top disease conditions for Apocynin
Top clinical trial sponsors for Apocynin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Apocynin||⤷ Try it Free||Selectivity of the production of vanilloids in a recombinant unicellular host||RHODIA OPERATIONS (Paris, FR)||⤷ Try it Free|
|Apocynin||⤷ Try it Free||Polyurethane fiber||TORAY OPELONTEX CO., LTD. (Osaka, JP)||⤷ Try it Free|
|Apocynin||⤷ Try it Free||Compounds for promoting liposomal and cellular adhesion and compositions and methods of use thereof||ORGANOLINX CORP. (Mississauga, CA)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Apocynin||China||CN106574269||2034-06-18||⤷ Try it Free|
|Apocynin||European Patent Office||EP2957635||2034-06-18||⤷ Try it Free|
|Apocynin||European Patent Office||EP3158069||2034-06-18||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|